Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.

Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

Fisman EZ, Tenenbaum A.

Cardiovasc Diabetol. 2014 Jun 23;13(1):103. [Epub ahead of print]

PMID:
24957699
[PubMed - as supplied by publisher]
Free Article
2.

Authors' response.

Fisman EZ, Tenenbaum A.

Cardiol J. 2014;21(2):210. doi: 10.5603/CJ.2014.0033. No abstract available.

PMID:
24752953
[PubMed - in process]
3.

Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns.

Shemesh J, Tenenbaum A, Fisman EZ, Koren-Morag N, Grossman E.

Cardiovasc Diabetol. 2013 Nov 5;12(1):161. doi: 10.1186/1475-2840-12-161.

PMID:
24188692
[PubMed - in process]
Free Article
4.

Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.

Klempfner R, Goldenberg I, Fisman EZ, Matetzky S, Amit U, Shemesh J, Tenenbaum A.

Am J Cardiol. 2014 Jan 1;113(1):12-6. doi: 10.1016/j.amjcard.2013.08.033. Epub 2013 Oct 2.

PMID:
24157192
[PubMed - indexed for MEDLINE]
5.

Bezafibrate treatment is associated with a reduced rate of re-hospitalization in smokers after acute coronary syndrome.

Klempfner R, Goldenberg I, Fisman EZ, Amit U, Haitovich A, Matetzky S, Medvedofsky D, Shemesh J, Tenenbaum A.

Cardiol J. 2014 Mar 27. doi: 10.5603/CJ.a2013.0127. [Epub ahead of print]

PMID:
24142677
[PubMed - as supplied by publisher]
Free Article
6.

Optimal revascularization in diabetes after the FREEDOM trial: were the controversies finally settled?

Tenenbaum A, Fisman EZ.

Cardiol J. 2013;20(4):331-6. doi: 10.5603/CJ.2013.0090.

PMID:
23913450
[PubMed - in process]
Free Article
7.

The metabolic syndrome entanglement: Cutting the Gordian knot.

Fisman EZ, Tenenbaum A.

Cardiol J. 2014;21(1):1-5. doi: 10.5603/CJ.a2013.0054. Epub 2013 May 15.

PMID:
23677720
[PubMed - in process]
8.

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2012 Nov 14;11:140. doi: 10.1186/1475-2840-11-140. Review.

PMID:
23150952
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2012 Oct 11;11:125. doi: 10.1186/1475-2840-11-125. Review.

PMID:
23057687
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease.

Klempfner R, Leor J, Tenenbaum A, Fisman EZ, Goldenberg I.

Cardiovasc Diabetol. 2012 Jun 6;11:60. doi: 10.1186/1475-2840-11-60.

PMID:
22672501
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data.

Tenenbaum A, Medvedofsky D, Fisman EZ, Bubyr L, Matetzky S, Tanne D, Klempfner R, Shemesh J, Goldenberg I.

PLoS One. 2012;7(4):e35298. doi: 10.1371/journal.pone.0035298. Epub 2012 Apr 16.

PMID:
22523582
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The doubtful association between blood lipid changes and progression of coronary calcification.

Tenenbaum A, Fisman EZ, Shemesh J, Motro M.

Int J Cardiol. 2011 Dec 1;153(2):224-5. doi: 10.1016/j.ijcard.2011.09.058. Epub 2011 Oct 11. No abstract available.

PMID:
21996414
[PubMed - indexed for MEDLINE]
13.

Fibrate use in the United States and Canada.

Tenenbaum A, Fisman EZ.

JAMA. 2011 Jul 13;306(2):157; author reply 158-9. doi: 10.1001/jama.2011.945. No abstract available.

PMID:
21750290
[PubMed - indexed for MEDLINE]
14.

"The metabolic syndrome... is dead": these reports are an exaggeration.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2011 Jan 27;10(1):11. doi: 10.1186/1475-2840-10-11.

PMID:
21269524
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The ubiquitous interleukin-6: a time for reappraisal.

Fisman EZ, Tenenbaum A.

Cardiovasc Diabetol. 2010 Oct 11;9:62. doi: 10.1186/1475-2840-9-62.

PMID:
20937099
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

PMID:
20550659
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

Long-term changes in serum cholesterol level does not influence the progression of coronary calcification.

Tenenbaum A, Shemesh J, Koren-Morag N, Fisman EZ, Adler Y, Goldenberg I, Tanne D, Hay I, Schwammenthal E, Motro M.

Int J Cardiol. 2011 Jul 15;150(2):130-4. doi: 10.1016/j.ijcard.2010.03.001. Epub 2010 Mar 29.

PMID:
20350769
[PubMed - indexed for MEDLINE]
19.

A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.

Fisman EZ, Tenenbaum A.

Cardiovasc Diabetol. 2009 Jul 20;8:38. doi: 10.1186/1475-2840-8-38. Review.

PMID:
19619327
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic disease.

Tanne D, Tenenbaum A, Boyko V, Benderly M, Fisman EZ, Matas Z, Adler Y, Behar S.

Eur J Neurol. 2009 Nov;16(11):1217-23. doi: 10.1111/j.1468-1331.2009.02694.x. Epub 2009 Jun 15.

PMID:
19538221
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk